Evidence map›Paper›PMID 33079601›Full record

ArticleCirculation. Genomic and precision medicine2020

Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes.

Dipender Gill, Stephen Burgess

Open access · hybridAbstract readLetter
In one paragraph

Article in Circulation. Genomic and precision medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dipender GillDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom (D.G.).
Stephen BurgessMedical Research Council Biostatistics Unit, Cambridge Institute of Public Health (S.B.).
Imperial College London · GBPrimary Health Care · QA

Funding

British Heart Foundation RE/18/4/34215Medical Research Council MC_UU_00002/7Wellcome Trust 203928/Z/16/ZWellcome Trust 204623Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary Artery DiseaseFactor XaFactor Xa InhibitorsHumansMendelian Randomization AnalysisPolymorphism, Single NucleotideRiskFactor XaFactor Xa Inhibitorscardiovascular diseasecoronary artery diseaseMendelian randomization analysisserine protease

Identifiers

PMID33079601
PMCPMC7676614
OpenAlexW3049417040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.